Wells Fargo’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-304,963
| Closed | -$5.75M | – | 7041 |
|
|
2019
Q3 | $5.75M | Buy |
304,963
+163,957
| +116% | +$1.88M | ﹤0.01% | 2417 |
|
|
2019
Q2 | $1.66M | Buy |
141,006
+6,485
| +5% | +$78.5K | ﹤0.01% | 3505 |
|
|
2019
Q1 | $1.84M | Buy |
134,521
+20,758
| +18% | +$269K | ﹤0.01% | 3427 |
|
|
2018
Q4 | $1.17M | Sell |
113,763
-66,413
| -37% | -$850K | ﹤0.01% | 3718 |
|
|
2018
Q3 | $3M | Sell |
180,176
-32,440
| -15% | -$586K | ﹤0.01% | 3066 |
|
|
2018
Q2 | $3.36M | Buy |
212,616
+63,825
| +43% | +$970K | ﹤0.01% | 3031 |
|
|
2018
Q1 | $1.89M | Buy |
148,791
+41,985
| +39% | +$607K | ﹤0.01% | 3428 |
|
|
2017
Q4 | $1.22M | Sell |
106,806
-66,091
| -38% | -$738K | ﹤0.01% | 3787 |
|
|
2017
Q3 | $2.12M | Buy |
172,897
+37,826
| +28% | +$394K | ﹤0.01% | 3269 |
|
|
2017
Q2 | $1.55M | Buy |
135,071
+33,526
| +33% | +$620K | ﹤0.01% | 3391 |
|
|
2017
Q1 | $2.11M | Sell |
101,545
-271,074
| -73% | -$6M | ﹤0.01% | 3162 |
|
|
2016
Q4 | $7.75M | Buy |
372,619
+110,437
| +42% | +$2.87M | ﹤0.01% | 2050 |
|
|
2016
Q3 | $8.59M | Sell |
262,182
-299,540
| -53% | -$9.12M | ﹤0.01% | 1862 |
|
|
2016
Q2 | $14M | Buy |
561,722
+285,663
| +103% | +$7.73M | 0.01% | 1563 |
|
|
2016
Q1 | $6.76M | Buy |
276,059
+6,285
| +2% | +$146K | ﹤0.01% | 2084 |
|
|
2015
Q4 | $8.91M | Buy |
269,774
+200,707
| +291% | +$6.79M | ﹤0.01% | 1924 |
|
|
2015
Q3 | $2.26M | Sell |
69,067
-1,857
| -3% | -$78.9K | ﹤0.01% | 2906 |
|
|
2015
Q2 | $3.76M | Buy |
70,924
+12,369
| +21% | +$450K | ﹤0.01% | 2617 |
|
|
2015
Q1 | $1.69M | Buy |
58,555
+51,312
| +708% | +$1.41M | ﹤0.01% | 3153 |
|
|
2014
Q4 | $211K | Sell |
7,243
-20,982
| -74% | -$377K | ﹤0.01% | 4387 |
|
|
2014
Q3 | $358K | Sell |
28,225
-10,098
| -26% | -$153K | ﹤0.01% | 4083 |
|
|
2014
Q2 | $769K | Buy |
+38,323
| New | +$540K | ﹤0.01% | 3683 |
|